Gynecology & Obstetrics
Open Access
ISSN: 2161-0932
ISSN: 2161-0932
Seiryu Kamoi
Chiba Hokusoh Hospital,
1715 Kamagari, Inzai, Chiba
Japan
Case Report
Relapse as Advanced Carcinosarcoma Following Uterus-Preserving Therapy in a Patient with Early-Staged and Grade 1 Endometrioid Adenocarcinoma: A Case Report and Review of the Literature
Author(s): Seiryu Kamoi, Marie Ito, Akihito Yamamoto, Atsuko Ishikawa, Takashi Yamada and Toshiyuki TakeshitaSeiryu Kamoi, Marie Ito, Akihito Yamamoto, Atsuko Ishikawa, Takashi Yamada and Toshiyuki Takeshita
Fertility-sparing treatment with high-dose progestin is now used in many young patients with early stage, grade 1 endometrioid adenocarcinoma. The response rate of this therapy is quite good, but the relapse rate is relatively high. If the site of recurrence is limited to the uterus, this may be treated with additional hormone therapy or hysterectomy. We recently experienced a case of a 30-year-old primigravida patient in whom intraperitoneal dissemination of carcinosarcoma occurred during follow-up after apparent complete remission of early-stage grade 1 endometrioid adenocarcinoma. We report the case as an example of a rare high-grade histology tumor that relapsed in an extrauterine site after primary remission had been achieved with high-dose progestin therapy. In a review of the literature through a MEDLINE search, we found 13 articles describing relapse in an extrauterine site, i.. View More»
DOI:
10.4172/2161-0932.1000216